16-30417562-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001142305.2(ZNF771):c.149G>A(p.Gly50Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000027 in 1,220,914 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001142305.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF771 | NM_001142305.2 | c.149G>A | p.Gly50Asp | missense_variant | 3/3 | ENST00000319296.10 | NP_001135777.1 | |
ZNF771 | NM_016643.4 | c.149G>A | p.Gly50Asp | missense_variant | 3/3 | NP_057727.2 | ||
ZNF771 | XM_047434196.1 | c.224G>A | p.Gly75Asp | missense_variant | 3/3 | XP_047290152.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF771 | ENST00000319296.10 | c.149G>A | p.Gly50Asp | missense_variant | 3/3 | 1 | NM_001142305.2 | ENSP00000323945.5 | ||
ZNF771 | ENST00000566625.2 | c.141+9368G>A | intron_variant | 1 | ENSP00000460549.1 | |||||
ZNF771 | ENST00000434417.1 | c.149G>A | p.Gly50Asp | missense_variant | 3/3 | 2 | ENSP00000416197.1 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 151952Hom.: 0 Cov.: 33
GnomAD4 exome AF: 0.0000234 AC: 25AN: 1068850Hom.: 0 Cov.: 30 AF XY: 0.0000257 AC XY: 13AN XY: 505322
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152064Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74362
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 22, 2024 | The c.149G>A (p.G50D) alteration is located in exon 3 (coding exon 2) of the ZNF771 gene. This alteration results from a G to A substitution at nucleotide position 149, causing the glycine (G) at amino acid position 50 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at